- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01520376
Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD (ADPHA-EPOC)
July 5, 2018 updated by: Nestor Soler Porcar, MD, PhD
A Prospective Randomized Trial to Asses the Efficacy of an Early Psychiatric Counseling Compared to Usual Care in a Cohort of Patients Hospitalized for an Acute Exacerbation of COPD in Prevention of Re-exacerbation
This study will try to elucidate wheter the impact of a psychiatric intervention in patients hospitalized because an acute exacerbation of COPD and anxiety/depression and reconsulting at 1 and 6 month after discharge.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
169
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Catalonia
-
Barcelona, Catalonia, Spain, 08036
- Fundacio Clinic Per la Recerca Biomèdica - Hospital Clinic de Barcelona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women of any ethnic group
- Above 40 years old
- Diagnose with Chronic Obstructive Pulmonary disease (COPD) according to the ATS/ERS guidelines
Acute exacerbation of COPD according to the following criteria:
a) Cyanosis b) Obnubilations or mental confusion d) Respiratory Rate above 25 per minute e) Failure of ambulatory treatment f) Co-morbidities that worsens respiratory condition g) Dyspnea
Exclusion Criteria:
- Less than 6 months expectancy of life
- Needing of mechanical ventilation
- Severe cardiovascular disease
- Pregnancy
- Previous diagnosis of depression/anxiety
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Counselling
People receiving a psychiatric evaluation after screening (HADS test > 12 points) and revised at 1 and 6 months
|
Visit by a psychiatrist at day-30 and day-180 after discarge
|
NO_INTERVENTION: Usual care
People after screening (HADS test > 12 points) and send to their primary care physician
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of the intervention
Time Frame: 6 months
|
Counselling vs. usual care on re-hospitalizations
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of diagnosis
Time Frame: 6 months
|
Anxiety/depression diagnosis on number of exacerbations at 1 and 6 months, comparing patients with screening on HADS test > 12
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arturo Huerta, MD, Hospital Clinic of Barcelona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (ACTUAL)
October 1, 2013
Study Completion (ACTUAL)
April 1, 2014
Study Registration Dates
First Submitted
January 25, 2012
First Submitted That Met QC Criteria
January 25, 2012
First Posted (ESTIMATE)
January 27, 2012
Study Record Updates
Last Update Posted (ACTUAL)
July 6, 2018
Last Update Submitted That Met QC Criteria
July 5, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ADPHA-EPOC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Counselling
-
Children's Hospital of Eastern OntarioLondon Health Sciences Centre; Stollery Children's Hospital; Ontario Child Health... and other collaboratorsCompletedCongenital Heart DiseaseCanada
-
Azienda Ospedaliera Città della Salute e della...CompletedAdolescent | Child | Hematopoietic Stem Cell TransplantationItaly
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR)Completed
-
Shenzhen Smoore Technology LimitedWithdrawn
-
University of AlbertaDanone Institute InternationalCompleted
-
Swinburne University of TechnologyUS Department of Veterans AffairsTerminated
-
The University of Hong KongActive, not recruiting
-
University of Nigeria, Enugu CampusUniversity of Glasgow; University Of Nigeria Teaching HospitalUnknownEssential HypertensionNigeria
-
Eivind MelandUniversity of AgderCompleted
-
VTT Technical Research Centre of FinlandTechnical University of Denmark; Firstbeat Technologies Ltd.; Mawell Care Ltd; Mawell... and other collaboratorsCompletedPsychological Stress